Report outlines 17 targeted actions to address structural barriers hindering leadership progression Copenhagen / Oslo / Stockholm, April 17, 2026 — The Nordic life science sector is losing highly qualified female talent in top leadership positions, according to a new white paper published by Women in Life Science Denmark (WiLD), WiLD Norway, and VILDA Sweden. […]
Easter may be over, but momentum across life sciences is building. Anglonordic Life Science Conference is less than two weeks away, alongside a steady stream of clinical progress, partnerships, and industry milestones, it’s all go! Our latest Optimum TV episode features Stephen Hansen of BioCentury and offers fresh insights into market trends and the Q2 […]
PDUFA action date for Hansa Biopharma’s imlifidase BLA set for December 19, 2026 Hansa Biopharma announced that the Food and Drug Administration (FDA) has notified the company that the previously accepted Biologics License Application (BLA) for imlifidase has been assigned a Prescription Drug User Fee Act (PDUFA) action date of December 19, 2026. 📺Optimum TV […]
Novo Nordisk Foundation announced it had awarded DKK 11.8 billion (€1.6 billion) during 2025 to support more than 2,200 projects aimed at improving people’s health and the sustainability of society and the planet. The projects cover the full range of the Foundation’s grant-giving areas, including key topics such as cardiometabolic diseases, antimicrobial resistance, the development of more resilient and climate-friendly […]
Biocomposites launches SYNICEM™ spacers in Canada Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in infection management in bone and soft tissue, has launched its SYNICEM™ hip, knee and shoulder preformed spacers in Canada. It follows the launch of the same products in the US last October. Biocomposites, […]
